UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

Archives of toxicology, 2014-07, Vol.88 (7), p.1351-1389

2014

Volltextzugriff (PDF)

Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients

Clinical pharmacokinetics, 2015-10, Vol.54 (10), p.993-1025

2015

Volltextzugriff (PDF)

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

Clinical pharmacokinetics, 2007, Vol.46 (1), p.13-58

2007

Volltextzugriff (PDF)

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

Clinical pharmacokinetics, 2010-03, Vol.49 (3), p.141-175

2010

Volltextzugriff (PDF)

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

Clinical pharmacokinetics, 2010-04, Vol.49 (4), p.207-221

2010

Volltextzugriff (PDF)

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

Clinical pharmacokinetics, 2004-01, Vol.43 (10), p.623-653

2004

Volltextzugriff (PDF)

Conditional Weighted Residuals (CWRES) : A Model Diagnostic for the FOCE Method

Pharmaceutical research, 2007-12, Vol.24 (12), p.2187-2197

2007

Volltextzugriff (PDF)

Editorial: Therapeutic Drug Monitoring in Solid Organ Transplantation

Frontiers in pharmacology, 2021-12, Vol.12, p.815117-815117

2021

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients

Frontiers in pharmacology, 2021-04, Vol.12, p.635165

2021

Volltextzugriff (PDF)

Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

Clinical drug investigation, 2019-12, Vol.39 (12), p.1175-1184

2019

Volltextzugriff (PDF)

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Drugs in R&D, 2018-12, Vol.18 (4), p.271-282

2018

Volltextzugriff (PDF)

Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance

CPT: pharmacometrics and systems pharmacology, 2022-08, Vol.11 (8), p.1002-1017

2022

Volltextzugriff (PDF)

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

Transplantation reviews (Orlando, Fla.), 2011-04, Vol.25 (2), p.47-57

2011

Volltextzugriff (PDF)

Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients

Clinical pharmacokinetics, 2021, Vol.60 (1), p.17-51

2021

Volltextzugriff (PDF)

Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?

Clinical pharmacokinetics, 2016-11, Vol.55 (11), p.1295-1335

2016

Volltextzugriff (PDF)

NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation

Transplantation, 2012-11, Vol.94 (10), p.1025

2012

Volltextzugriff (PDF)

PharmGKB summary: cyclosporine and tacrolimus pathways

Pharmacogenetics and genomics, 2013-10, Vol.23 (10), p.563-585

2013

Volltextzugriff (PDF)

Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients

Translational andrology and urology, 2019-05, Vol.8 (Suppl 2), p.S198-S213

2019

Volltextzugriff (PDF)

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

Intensive care medicine, 2016-10, Vol.42 (10), p.1535-1545

2016

Volltextzugriff (PDF)

Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis

Clinical pharmacokinetics, 2015-04, Vol.54 (4), p.409-421

2015

Volltextzugriff (PDF)

Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis

European journal of clinical pharmacology, 2022-09, Vol.78 (9), p.1365-1376

2022

Volltextzugriff (PDF)

Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis

Sleep (New York, N.Y.), 2024-02, Vol.47 (2), p.1

2024

Volltextzugriff (PDF)

Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials

Transplantation, 2010-07, Vol.90 (1), p.44

2010

Volltextzugriff (PDF)

Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients

Antimicrobial agents and chemotherapy, 2016-06, Vol.60 (6), p.3407-3414

2016

Volltextzugriff (PDF)

Predictors of new onset diabetes after renal transplantation

Clinical transplantation, 2007-01, Vol.21 (1), p.136-143

2007

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(101)
Reviews
(1)

Sprache

Englisch
(102)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(91)
Science & Technology
(91)
Humans
(70)
Pharmacology & Pharmacy
(62)
Male
(42)
Female
(39)
Immunosuppressive Agents - Pharmacokinetics
(35)
Adult
(34)
Middle Aged
(32)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Pharmacology. Drug Treatments
(28)
Kidney Transplantation
(27)
Tacrolimus - Pharmacokinetics
(24)
Pharmacology/toxicology
(22)
Tacrolimus
(22)
Pharmacokinetics
(20)
Medicine
(19)
Medicine & Public Health
(19)
Immunosuppressive Agents - Administration & Dosage
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update

Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

Conditional Weighted Residuals (CWRES) : A Model Diagnostic for the FOCE Method

Editorial: Therapeutic Drug Monitoring in Solid Organ Transplantation

Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients

Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients

Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?

NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation

PharmGKB summary: cyclosporine and tacrolimus pathways

Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

Comparing Dosage Adjustment Methods for Once-Daily Tobramycin in Paediatric and Adolescent Patients with Cystic Fibrosis

Safety evaluation of oral calcitonin-gene–related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis

Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis

Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials

Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients

Predictors of new onset diabetes after renal transplantation

Suchergebnisse filtern